|
|
|
|
| LEADER |
01694nam a22002775i 4500 |
| 001 |
000279233 |
| 005 |
20220120121307.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592599646
|
| 024 |
7 |
|
|a 10.1385/1592599648
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Bioinformatics and Drug Discovery /
|c edited by Richard S. Larson.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2006.
|
| 300 |
|
|
|a X, 444 p. 103 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 316
|
| 505 |
0 |
|
|a New Strategies in Drug Discovery -- Basic Microarray Analysis -- From Microarray to Biological Networks -- Microarray Analysis in Drug Discovery and Clinical Applications -- Ontology-Driven Approaches to Analyzing Data in Functional Genomics -- Gene Evolution and Drug Discovery -- Standardization of Microarray and Pharmacogenomics Data -- Clinical Applications of Bioinformatics, Genomics, and Pharmacogenomics -- Protein Interactions Probed With Mass Spectrometry -- Discovering New Drug-Targeting Sites on Flexible Multidomain Protein Kinases -- Nuclear Magnetic Resonance-Based Screening Methods for Drug Discovery -- Receptor-Binding Sites -- In Silico Protein Design -- Chemical Database Preparation for Compound Acquisition or Virtual Screening -- Bioinformatics Platform Development.
|
| 650 |
|
0 |
|a Pharmacy.
|
| 650 |
1 |
4 |
|a Pharmacy.
|
| 700 |
1 |
|
|a Larson, Richard S.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|